Cell Cure Neurosciences, a majority-owned (>95%) Israeli subsidiary of Lineage Cell Therapeutics, Inc. a clinical-stage biotechnology company developing novel cell therapies for unmet medical needs. Our programs are based on as robust proprietary cell-based therapy platform and associated in-house process development and manufacturing capabilities. Our focus is on manufacturing, allogenic, at scale, specialized, terminally differentiated human cells from pluripotent and progenitor cell starting materials. These differentiated cells are developed to either replace or support cells that are dysfunctional or absent due to degenerative disease or traumatic injury or administered as a means of helping the body mount an effective immune response to cancer. Our presentation will described the approach, technology and understandings carrying out campaigns to support Lineages clinical programs: (i) OpRegen, a retinal pigment epithelium transplant therapy in Phase 1/2a development for the treatment of dry age-related macular degeneration, which is now being developed under a worldwide collaboration with Roche and Genentech, a member of the Roche Group; (ii) OPC1, an oligodendrocyte progenitor cell therapy in Phase 1/2a development for the treatment of acute spinal cord injuries; (iii) VAC2, a dendritic cell therapy produced from Lineage’s VAC technology platform for immuno-oncology and infectious disease, currently in Phase 1 clinical development for the treatment of non-small cell lung cancer and (iv) ANP1, an auditory neuronal progenitor cell therapy for the potential treatment of auditory neuropathy.
Company Details
- Employees
- 42
- Founded
- -
- Address
- Jerusalem, 91121, Il
- Phone
- 972 5 4524 5677
- in****@****e.co.il
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- cellcureneurosciences.com
- Keywords
- Embryonic stem cell research & development, Pluripotent stem cell research & development, research & development related to age-related macular degeneration, Research & development related to degenerative diseases of the eye.
- HQ
- Jerusalem
Cell Cure Neurosciences Ltd. Questions
Cell Cure Neurosciences Ltd.'s helpline number is 972 5 4524 5677
Cell Cure Neurosciences Ltd.'s website is cellcureneurosciences.com
Cell Cure Neurosciences Ltd.'s LinkedIn profile is https://il.linkedin.com/company/cell-cure-neurosciences-ltd-
Cell Cure Neurosciences Ltd. has
42 employees.
View email and phone details for 42
employees at Cell Cure Neurosciences Ltd..
Cell Cure Neurosciences Ltd.'s industry is
Biotechnology Research
Cell Cure Neurosciences Ltd.'s top competitors are
Neurogenesis Bio Inc.,
Anima Biotech,
Protalix Biotherapeutics,
Neurosense Therapeutics,
Cellcure,
Alomone Labs,
Brainstorm Cell Therapeutics,
Gamida Cell Ltd.,
Newstem Ltd.,
Lineage Cell Therapeutics.
Cell Cure Neurosciences Ltd.'s support email address is info@cellcure.co.il
Cell Cure Neurosciences Ltd.'s categories are Biotechnology Research
Cell Cure Neurosciences Ltd.'s founding year is 2008
